Evaluación positiva de medicamentos: 3.er trimestre 2012 Sanid. mil. 2012; 68 (4) 237 BIBLIOGRAFIA 1. Agencia Española de Medicamentos y Productos Sanitarios. Informe men-sual sobre medicamentos de Uso Humano y Productos Sanitario. Septiembre de 2012. Consultado10/10/2012. Disponible en URL. http://www.aemps.gob. es/informa/informeMensual/2012/septiembre/home.htm 2. Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2012. Consultado10/10/2012. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/ news/2012/09/news_detail_001607.jsp&mid=WC0b01ac058004d5c1 3. Committee for medical products for human use (CHMP). Eylea. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_ opinion__Initial_authorisation/human/002392/WC500132884.pdf 4. Food and Drug Administration . Aprovell labell Eylea. Disponible en: http:// www.accessdata.fda.gov/drugsatfda_docs/label/2011/125387lbl.pdf 5. Food and Drug Administration. Aprovell labell Eylea. Ultima revisión sep-tiembre 2012. Disponible en: http://www.accessdata.fda.gov/drugsatfda_ docs/label/2012/125387s004lbl.pdf 6. Agencia Española de Medicamentos y Productos Sanitarios. Informe men-sual sobre medicamentos de Uso Humano y Productos Sanitarios. Julio de 2012. Consultado10/10/2012. Disponible en URL http://www.aemps.gob.es/ informa/informeMensual/2012/julio/home.htm 7. Meeting highlights from the Committee for Medicinal Products for Hu-man Use (CHMP) 16-19 July 2012. (consultado10/10/2012). Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/ news/2012/07/news_detail_001568.jsp&mid=WC0b01ac058004d5c1 8. Committee for medical products for human use (CHMP). Glybera. Dispo-nible en: http://www.ema.europa.eu/docs/en_GB/document_library/Sum-mary_ of_opinion_Initial_authorisation/human/002145/WC500130151.pdf 9. Committee for medical products for human use (CHMP). Adcetris. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_ opinion__Initial_authorisation/human/002455/WC500130143.pdf 10. Stephanie S Minich et al. Brentuximab Vedotin: A New Age in the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma. Ann Phar-macother March 2012 46:377-383 11. Committee for medical products for human use (CHMP). NexoBrid. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_li-brary/ Summary_of_opinion__Initial_authorisation/human/002246/ WC500132880.pdf 12. Committee for medical products for human use (CHMP). Xalkori. Dispo-nible en: http://www.ema.europa.eu/docs/en_GB/document_library/Sum-mary_ of_opinion_Initial_authorisation/human/002489/WC500130138.pdf 13. Food and Drug Administration . Aprovell labell Xalkori. Disponible en: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl. pdf 14. Committee for medical products for human use (CHMP). Dacogen. Dispo-nible en: http://www.ema.europa.eu/docs/en_GB/document_library/Sum-mary_ of_opinion_Initial_authorisation/human/002221/WC500130136.pdf 15. Food and Drug Administration . Aprovell labell Dacogen. Disponible en: http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021790lbl.pdf 16. Committee for medical products for human use (CHMP). Picato. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_ opinion__Initial_authorisation/human/002275/WC500132881.pdf 17. Food and Drug Administration. Aprovell Labell Picato. Disponible en: http:// www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search. Label_ApprovalHistory#labelinfo 18. Committee for medical products for human use (CHMP). Constella. Dis-ponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Sum-mary_ of_opinion_Initial_authorisation/human/002490/WC500132840.pdf 19. FDA Aprovell labell Constella disponible en:http://www.accessdata.fda.gov/ drugsatfda_docs/label/2012/202811s000lbl.pdf 20. Anthony J. Lembo. M.D., Harvey A. Schneier. M.D. et al. Two Randomized Trials of Linaclotide for Chronic Constipacion. N England J Med 2011; 365: 527-536.
REVISTA DE SANIDAD DE LAS FAS DE ESPAÑA OCT_DIC 2012
To see the actual publication please follow the link above